2023 ESGO Vulvar Cancer Guidelines Update

In 2023, the ESGO has completed the update of the 2017 evidence-based guidelines of the management of patients with vulvar cancer. The international multidisciplinary working group led by Dr. Maaike Oonk, the project chair, involved experts in gynaecological oncology, medical oncology, radiation oncology, pathology as well as specialists in ultrasound and imaging. The topics include diagnosis, staging, pathology, preoperative investigations and surgical management including the sentinel lymph node procedure. The guidelines also cover (chemo)radiotherapy, systemic treatment, follow-up, treatment of recurrent disease and palliative and supportive care.

 

2023 Update of the Vulvar Cancer Guidelines 

ESGO Vulvar cancer guidelines - 2023 Update article
Vulvar Cancer Pocket Guidelines

2023 ESGO Vulvar Cancer Guidelines Working Group

The European Society of Gynaecological Oncology would like to express a sincere gratitude to the international experts panel, who devoted their time and effort to the development of the ESGO Guidelines for the Management of Patients with Vulvar Cancer.

Name	Specialty	Institution
Maaike H.M  Oonk	Gynecologic oncologist (chair)	University Medical Center Groningen, University of Groningen, Groningen (The Netherlands)
François Planchamp	Methodologist	Institut Bergonié, Bordeaux (France)
Peter Baldwin	Gynecologic oncologist	Addenbrooke’s Hospital, University Hospitals NHS Foundation Trust, Cambridge (United Kingdom)
Sven Mahner	Gynecologic oncologist	University Hospital, LMU Munich, Munich (Germany)
Mansoor Raza Mirza	Gynecologic oncologist	Rigshospitalet, Copenhagen (Denmark)
Daniela Fischerova	Gynecologic oncologist	First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague (Czech Republic)
Carien Creutzberg	Radiation oncologist	Leiden University Medical Center, Leiden (Netherlands)
Eugénie Guillot	Gynecologic oncologist	Institut Curie, Paris (France)
Giorgia Garganese	Gynecologic oncologist	Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (Italy)
Sigurd F. Lax	Pathologist	Hospital Graz II, Graz (Austria) School of Medicine, Johannes Kepler University, Linz (Austria)
Andres Redondo	Medical oncologist	La Paz University Hospital - IdiPAZ, Madrid (Spain)
Alina Emiliana Sturdza	Radiation oncologist	AKH/University Hospital Wien, Vienna (Austria)
Alexandra Taylor	Radiation oncologist	The Royal Marsden NHS Foundation Trust, London (United Kingdom)
Elena Ulrikh	Gynecologic oncologist	Almazov National Medical Research Centre, Saint-Petersburg (Russia)
Vincent Vandecaveye	Radiologist	University Hospitals Leuven, Leuven (Belgium)
Ate G.J. van der Zee	Gynecologic oncologist	University Medical Center Groningen, University of Groningen, Groningen (The Netherlands)
Linn Woelber	Gynecologic oncologist	University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
Diana Zach	Gynecologic oncologist	Karolinska University Hospital, Stockholm (Sweden) Karolinska Institutet Eugeniavägen, Stockholm (Sweden)
Gian Franco Zannoni	Histopathologist	Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome (Italy)
Ignacio Zapardiel	Gynecologic oncologist	La Paz University Hospital - IdiPAZ, Madrid (Spain)

 

 

External Reviewers

41 Countries – 195 Reviewers

ESGO would also like thank external reviewers who have taken the time to provide their feedback on the document elaborated in the framework of the ESGO Guidelines for the Management of Vulvar Cancer Project.

The list of the External Reviewers Panel